"Post Mastectomy Pain Syndrome: A Systematic Review of Prevention Modalities"

Selcen S Yuksel, Ava G Chappell, Brandon T Jackson, Annie B Wescott, Marco F Ellis, Selcen S Yuksel, Ava G Chappell, Brandon T Jackson, Annie B Wescott, Marco F Ellis

Abstract

Background: Post-mastectomy pain syndrome (PMPS) is a surgical complication of breast surgery characterized by chronic neuropathic pain. The development of PMPS is multifactorial and research on its prevention is limited. The objective of this systematic review is to synthesize the existing evidence on interventions for lowering the incidence of persistent neuropathic pain after breast surgery.

Methods: Using Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we performed a comprehensive search of the electronic databases of MEDLINE, Cochrane Library, Embase, CINAHL, PsycINFO, Web of Science, and ClinicalTrials.gov using a combination of database-specific controlled vocabulary and keyword searches. Two reviewers independently screened all unique records. Publications on chronic (>3-month duration) pain after breast cancer-related surgery were included. Studies were classified by modality.

Results: Our literature search yielded 7092 articles after deduplication. We identified 45 studies that met final inclusion criteria for analysis, including 37 randomized-controlled trials. These studies revealed seven major intervention modalities for prevention of PMPS: physical therapy, mindfulness-based cognitive therapy, oral medications, surgical intervention, anesthesia, nerve blocks, and topical medication therapy.

Conclusion: High-quality data on preventative techniques for PMPS are required to inform decisions for breast cancer survivors. We present a comprehensive assessment of the modalities available that can help guide breast and reconstructive surgeons employ effective strategies to lower the incidence and severity of PMPS. Our review supports the use of multimodal care involving both a peripherally targeted treatment and centrally acting medication to prevent the development of PMPS.

Keywords: neuropathic pain; post-mastectomy pain syndrome; prevention; systematic review.

Conflict of interest statement

Dr. Ellis, Ms. Yuksel, Dr. Chappell, Dr. Jackson and Ms. Wescott have nothing to disclose.

© 2021 The Authors.

Figures

Figure 1
Figure 1
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) diagram illustrating the flow of information through phases of the systematic review.

References

    1. Tait RC, Zoberi K, Ferguson M, et al. Persistent Post-Mastectomy Pain: Risk Factors and Current Approaches to Treatment. J Pain. 2018;19(12):1367–1383. doi: 10.1016/j.jpain.2018.06.002.
    1. Couceiro TC de M, Valença MM, Raposo MCF, Orange FA, Amorim MMR. Prevalence of post-mastectomy pain syndrome and associated risk factors: a cross-sectional cohort study. Pain Manag Nurs. 2014;15(4):731–737. doi: 10.1016/j.pmn.2013.07.011. de.
    1. Harvey AM. Classification of chronic pain—descriptions of chronic pain syndromes and definitions of pain terms. Clin J Pain. 1995;11(2):163. doi: 10.1097/00002508-199506000-00024.
    1. Chaparro LE, Smith SA, Moore RA, Wiffen PJ, Gilron I. Pharmacotherapy for the prevention of chronic pain after surgery in adults. Cochrane Database Syst Rev. 2013;(7) doi: 10.1002/14651858.CD008307.pub2.
    1. Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet. 2006;367(9522):1618–1625. doi: 10.1016/S0140-6736(06)68700-X.
    1. Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain. 2011;152(3 Suppl):S2–15. doi: 10.1016/j.pain.2010.09.030.
    1. Poleshuck EL, Katz J, Andrus CH, et al. Risk factors for chronic pain following breast cancer surgery: a prospective study. J Pain. 2006;7(9):626–634. doi: 10.1016/j.jpain.2006.02.007.
    1. Meretoja TJ, Leidenius MHK, Tasmuth T, Sipilä R, Kalso E. Pain at 12 months after surgery for breast cancer. JAMA. 2014;311(1):90–92. doi: 10.1001/jama.2013.278795.
    1. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336–341. doi: 10.1016/j.ijsu.2010.02.007.
    1. Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210. doi: 10.1186/s13643-016-0384-4.
    1. Ammitzbøll G, Andersen KG, Bidstrup PE, et al. Effect of progressive resistance training on persistent pain after axillary dissection in breast cancer: a randomized controlled trial. Breast Cancer Res Treat. 2020;179(1):173–183. doi: 10.1007/s10549-019-05461-z.
    1. De Groef A, Van Kampen M, Vervloesem N, et al. Myofascial techniques have no additional beneficial effects to a standard physical therapy programme for upper limb pain after breast cancer surgery: a randomized controlled trial. Clin Rehabil. 2017;31(12):1625–1635. doi: 10.1177/0269215517708605.
    1. Lacroix C, Duhoux FP, Bettendorff J, et al. Impact of perioperative hypnosedation on postmastectomy chronic pain: preliminary results. Integr Cancer Ther. 2019;18 doi: 10.1177/1534735419869494.
    1. Garssen B, Boomsma MF, Meezenbroek E de J, et al. Stress management training for breast cancer surgery patients. Psychooncology. 2013;22(3):572–580. doi: 10.1002/pon.3034.
    1. Strazisar B, Besic N. Comparison of continuous local anaesthetic and systemic pain treatment after axillary lymphadenectomy in breast carcinoma patients - a prospective randomized study. Radiol Oncol. 2013;47(2):145–153. doi: 10.2478/raon-2013-0018.
    1. Albi-Feldzer A, Mouret-Fourme E E, Hamouda S, et al. A double-blind randomized trial of wound and intercostal space infiltration with ropivacaine during breast cancer surgery: effects on chronic postoperative pain. Anesthesiology. 2013;118(2):318–326. doi: 10.1097/ALN.0b013e31827d88d8.
    1. Mohamed SA-B, Abdel-Ghaffar HS, Kamal SM, Fares KM, Hamza HM. Effect of topical morphine on acute and chronic postmastectomy pain: what is the optimum dose? Reg Anesth Pain Med. 2016;41(6):704–710. doi: 10.1097/AAP.0000000000000496.
    1. De Cassai A, Bonanno C, Sandei L, Finozzi F, Carron M, Marchet A. PECS II block is associated with lower incidence of chronic pain after breast surgery. Korean J Pain. 2019;32(4):286–291. doi: 10.3344/kjp.2019.32.4.286.
    1. Besch G, Lagrave-Safranez C, Ecarnot F, et al. Pectoral nerve block and persistent pain following breast cancer surgery: an observational cohort study. Minerva Anestesiol. 2018;84(6):769–771. doi: 10.23736/S0375-9393.18.12544-2.
    1. Fujii T, Shibata Y, Akane A, et al. A randomised controlled trial of pectoral nerve-2 (PECS 2) block vs. serratus plane block for chronic pain after mastectomy. Anaesthesia. 2019;74(12):1558–1562. doi: 10.1111/anae.14856.
    1. Gacio MF, Lousame AMA, Pereira S, Castro C, Santos J. Paravertebral block for management of acute postoperative pain and intercostobrachial neuralgia in major breast surgery. Braz J Anesthesiol. 2016;66(5):475–484. doi: 10.1016/j.bjane.2015.02.007.
    1. Qian B, Fu S, Yao Y, Lin D, Huang L. Preoperative ultrasound-guided multilevel paravertebral blocks reduce the incidence of postmastectomy chronic pain: a double-blind, placebo-controlled randomized trial. J Pain Res. 2019;12:597–603. doi: 10.2147/JPR.S190201.
    1. Shimizu H, Kamiya Y, Nishimaki H, Denda S, Baba H. Thoracic paravertebral block reduced the incidence of chronic postoperative pain for more than 1 year after breast cancer surgery. JA Clin Rep. 2015;1(1):19. doi: 10.1186/s40981-015-0023-4.
    1. Karmakar MK, Samy W, Li JW, et al. Thoracic paravertebral block and its effects on chronic pain and health-related quality of life after modified radical mastectomy. Reg Anesth Pain Med. 2014;39(4):289–298. doi: 10.1097/AAP.0000000000000113.
    1. Kamal SM, Ahmed BM, Refaat A. Effect of ketamine–bupivacaine combination in multilevel ultrasound- assisted thoracic paravertebral block on acute and chronic post-mastectomy pain. Egyptian Journal of Anaesthesia. 2019;35(1):33–41. doi: 10.1080/11101849.2019.1589715.
    1. Kairaluoma PM, Bachmann MS, Rosenberg PH, Pere PJ. Preincisional paravertebral block reduces the prevalence of chronic pain after breast surgery. Anesth Analg. 2006;103(3):703–708. doi: 10.1213/01.ane.0000230603.92574.4e.
    1. Ilfeld BM, Madison SJ, Suresh PJ, et al. Persistent postmastectomy pain and pain-related physical and emotional functioning with and without a continuous paravertebral nerve block: a prospective 1-year follow-up assessment of a randomized, triple-masked, placebo-controlled study. Ann Surg Oncol. 2015;22(6):2017–2025. doi: 10.1245/s10434-014-4248-7.
    1. Elkaradawy S, Nasr M, Elkerm Y, Deeb ME, Yassine O. The effect of multimodal balanced anaesthesia and long term gabapentin on neuropathic pain, nitric oxide and interleukin-1β following breast surgery. Egyptian Journal of Anaesthesia. 2012;28(1):67–78. doi: 10.1016/j.egja.2011.10.005.
    1. Cho A-R, Kwon J-Y, Kim K-H, et al. The effects of anesthetics on chronic pain after breast cancer surgery. Anesth Analg. 2013;116(3):685–693. doi: 10.1213/ANE.0b013e31827ee372.
    1. Grigoras A, Lee P, Sattar F, Shorten G. Perioperative intravenous lidocaine decreases the incidence of persistent pain after breast surgery. Clin J Pain. 2012;28(7):567–572. doi: 10.1097/AJP.0b013e31823b9cc8.
    1. Sun M, Liao Q, Wen L, Yan X, Zhang F, Ouyang W. Effect of perioperative intravenous flurbiprofen axetil on chronic postmastectomy pain. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2013;38(7):653–660. doi: 10.3969/j.issn.1672-7347.2013.07.001.
    1. Lefebvre-Kuntz D, Dualé C, Albi-Feldzer A, et al. General anaesthetic agents do not influence persistent pain after breast cancer surgery: A prospective nationwide cohort study. Eur J Anaesthesiol. 2015;32(10):697–704. doi: 10.1097/EJA.0000000000000215.
    1. Kang C, Cho A-R, Kim K-H, et al. Effects of Intraoperative Low-Dose Ketamine on Persistent Postsurgical Pain after Breast Cancer Surgery: A Prospective, Randomized, Controlled, Double-Blind Study. Pain Physician. 2020;23(1):37–47.
    1. Kendall MC, McCarthy RJ, Panaro S, et al. The Effect of Intraoperative Systemic Lidocaine on Postoperative Persistent Pain Using Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials Criteria Assessment Following Breast Cancer Surgery: A Randomized, Double-Blind, Placebo-Controlled Trial. Pain Pract. 2018;18(3):350–359. doi: 10.1111/papr.12611.
    1. Kim MH, Lee KY, Park S, Kim SI, Park HS, Yoo YC. Effects of systemic lidocaine versus magnesium administration on postoperative functional recovery and chronic pain in patients undergoing breast cancer surgery: A prospective, randomized, double-blind, comparative clinical trial. PLoS ONE. 2017;12(3) doi: 10.1371/journal.pone.0173026.
    1. Jain G, Bansal P, Ahmad B, Singh DK, Yadav G. Effect of the perioperative infusion of dexmedetomidine on chronic pain after breast surgery. Indian J Palliat Care. 2012;18(1):45–51. doi: 10.4103/0973-1075.97354.
    1. Khan JS, Hodgson N, Choi S, et al. Perioperative pregabalin and intraoperative lidocaine infusion to reduce persistent neuropathic pain after breast cancer surgery: A multicenter, factorial, randomized, controlled pilot trial. J Pain. 2019;20(8):980–993. doi: 10.1016/j.jpain.2019.02.010.
    1. Terkawi AS, Sharma S, Durieux ME, Thammishetti S, Brenin D, Tiouririne M. Perioperative lidocaine infusion reduces the incidence of post-mastectomy chronic pain: a double-blind, placebo-controlled randomized trial. Pain Physician. 2015;18(2):E139–E146.
    1. Fassoulaki A, Patris K, Sarantopoulos C, Hogan Q. The analgesic effect of gabapentin and mexiletine after breast surgery for cancer. Anesth Analg. 2002;95(4):985–991. doi: 10.1097/00000539-200210000-00036. table of contents.
    1. Lee, McAuliffe N, Dunlop, Palanisamy, Shorten. A comparison of the effects of two analgesic regimens on the development of persistent post-surgical pain (PPSP) after breast surgery.
    1. van Helmond N, Steegers MA, Filippini-de Moor GP, Vissers KC, Wilder-Smith OH. Hyperalgesia and Persistent Pain after Breast Cancer Surgery: A Prospective Randomized Controlled Trial with Perioperative COX-2 Inhibition. PLoS ONE. 2016;11(12) doi: 10.1371/journal.pone.0166601.
    1. Vig S, Kumar V, Deo S, Bhan S, Mishra S, Bhatnagar S. Effect of Perioperative Pregabalin on Incidence of Chronic Postmastectomy Pain Syndrome: A Prospective Randomized Placebo-Controlled Pilot Study. Indian J Palliat Care. 2019;25(4):508–513. doi: 10.4103/IJPC.IJPC_85_19.
    1. Reyad RM, Omran AF, Abbas DN, et al. The Possible Preventive Role of Pregabalin in Postmastectomy Pain Syndrome: A Double-Blinded Randomized Controlled Trial. J Pain Symptom Manage. 2019;57(1):1–9. doi: 10.1016/j.jpainsymman.2018.10.496.
    1. Fassoulaki A, Sarantopoulos C, Melemeni A, Hogan Q. Regional block and mexiletine: the effect on pain after cancer breast surgery. Reg Anesth Pain Med. 2001;26(3):223–228. doi: 10.1053/rapm.2001.23205.
    1. Hah J, Mackey SC, Schmidt P, et al. Effect of perioperative gabapentin on postoperative pain resolution and opioid cessation in a mixed surgical cohort: A randomized clinical trial. JAMA Surg. 2018;153(4):303–311. doi: 10.1001/jamasurg.2017.4915.
    1. Amr YM, Yousef AAA-M. Evaluation of efficacy of the perioperative administration of Venlafaxine or gabapentin on acute and chronic postmastectomy pain. Clin J Pain. 2010;26(5):381–385. doi: 10.1097/AJP.0b013e3181cb406e.
    1. Fassoulaki A, Triga A, Melemeni A, Sarantopoulos C. Multimodal analgesia with gabapentin and local anesthetics prevents acute and chronic pain after breast surgery for cancer. Anesth Analg. 2005;101(5):1427–1432. doi: 10.1213/01.ANE.0000180200.11626.8E.
    1. Na H-S, Oh A-Y, Koo B-W, Lim D-J, Ryu J-H, Han J-W. Preventive Analgesic Efficacy of Nefopam in Acute and Chronic Pain After Breast Cancer Surgery: A Prospective, Double-Blind, and Randomized Trial. Medicine (Baltimore) 2016;95(20):e3705. doi: 10.1097/MD.0000000000003705.
    1. Lo KK, Aycock JK. A blinded randomized controlled trial to evaluate the use of botulinum toxin for pain control in breast reconstruction with tissue expanders. Ann Plast Surg. 2015;74(3):281–283. doi: 10.1097/SAP.0b013e31829be8d8.
    1. Tasmuth T, Blomqvist C, Kalso E. Chronic post-treatment symptoms in patients with breast cancer operated in different surgical units. Eur J Surg Oncol. 1999;25(1):38–43. doi: 10.1053/ejso.1998.0597.
    1. Torresan RZ, Cabello C, Conde DM, Brenelli HB. Impact of the preservation of the intercostobrachial nerve in axillary lymphadenectomy due to breast cancer. Breast J. 2003;9(5):389–392. doi: 10.1046/j.1524-4741.2003.09505.x.
    1. Yang EJ, Kang E, Jang JY, et al. Effect of a mixed solution of sodium hyaluronate and carboxymethyl cellulose on upper limb dysfunction after total mastectomy: a double-blind, randomized clinical trial. Breast Cancer Res Treat. 2012;136(1):187–194. doi: 10.1007/s10549-012-2272-5.
    1. Freeman SRM, Washington SJ, Pritchard T, Barr L, Baildam AD, Bundred NJ. Long term results of a randomised prospective study of preservation of the intercostobrachial nerve. Eur J Surg Oncol. 2003;29(3):213–215. doi: 10.1053/ejso.2002.1409.
    1. Taira N, Shimozuma K, Ohsumi S, et al. Impact of preservation of the intercostobrachial nerve during axillary dissection on sensory change and health-related quality of life 2 years after breast cancer surgery. Breast Cancer. 2014;21(2):183–190. doi: 10.1007/s12282-012-0374-x.
    1. Salmon RJ, Ansquer Y, Asselain B. Preservation versus section of intercostal-brachial nerve (IBN) in axillary dissection for breast cancer–a prospective randomized trial. Eur J Surg Oncol. 1998;24(3):158–161. doi: 10.1016/s0748-7983(98)92793-7.
    1. Fassoulaki A, Sarantopoulos C, Melemeni A, Hogan Q. EMLA reduces acute and chronic pain after breast surgery for cancer. Reg Anesth Pain Med. 2000;25(4):350–355. doi: 10.1097/00115550-200007000-00005.
    1. Meijuan Y, Zhiyou P, Yuwen T, Ying F, Xinzhong C. A retrospective study of postmastectomy pain syndrome: incidence, characteristics, risk factors, and influence on quality of life. ScientificWorldJournal. 2013;2013 doi: 10.1155/2013/159732.
    1. Woolf CJ. Evidence for a central component of post-injury pain hypersensitivity. Nature. 1983;306(5944):686–688. doi: 10.1038/306686a0.
    1. Koppert W, Ostermeier N, Sittl R, Weidner C, Schmelz M. Low-dose lidocaine reduces secondary hyperalgesia by a central mode of action. Pain. 2000;85(1-2):217–224. doi: 10.1016/s0304-3959(99)00268-7.
    1. Kaur N, Jain A. Post mastectomy Chronic Pain in Breast Cancer Survivors: An Update on Definition, Pathogenesis, Risk Factors,Treatment and Prevention. Clin Oncol. 2017;2:1293.
    1. Jung BF, Ahrendt GM, Oaklander AL, Dworkin RH. Neuropathic pain following breast cancer surgery: proposed classification and research update. Pain. 2003;104(1-2):1–13. doi: 10.1016/s0304-3959(03)00241-0.
    1. Steegers MA, Wolters B, Evers AW, Strobbe L, Wilder-Smith OH. Effect of axillary lymph node dissection on prevalence and intensity of chronic and phantom pain after breast cancer surgery. J Pain. 2008;9(9):813–822. doi: 10.1016/j.jpain.2008.04.001.
    1. Miguel R, Kuhn AM, Shons AR, et al. The effect of sentinel node selective axillary lymphadenectomy on the incidence of postmastectomy pain syndrome. Cancer Control. 2001;8(5):427–430. doi: 10.1177/107327480100800506.
    1. Spivey TL, Gutowski ED, Zinboonyahgoon N, et al. Chronic pain after breast surgery: A prospective, observational study. Ann Surg Oncol. 2018;25(10):2917–2924. doi: 10.1245/s10434-018-6644-x.
    1. Baron RH, Fey JV, Borgen PI, Stempel MM, Hardick KR, Van Zee KJ. Eighteen sensations after breast cancer surgery: a 5-year comparison of sentinel lymph node biopsy and axillary lymph node dissection. Ann Surg Oncol. 2007;14(5):1653–1661. doi: 10.1245/s10434-006-9334-z.
    1. Fu Y, Chung D, Cao M-A, Apple S, Chang H. Is axillary lymph node dissection necessary after sentinel lymph node biopsy in patients with mastectomy and pathological N1 breast cancer? Ann Surg Oncol. 2014;21(13):4109–4123. doi: 10.1245/s10434-014-3814-3.
    1. Henderson JR, Tao A, Kirwan CC, Barr L. Immediate breast reconstruction does not increase postmastectomy pain. Ann Surg Oncol. 2014;21(1):113–117. doi: 10.1245/s10434-013-3293-y.
    1. Andersen KG, Kehlet H. Persistent pain after breast cancer treatment: a critical review of risk factors and strategies for prevention. J Pain. 2011;12(7):725–746. doi: 10.1016/j.jpain.2010.12.005.
    1. Weinrib AZ, Azam MA, Birnie KA, Burns LC, Clarke H, Katz J. The psychology of chronic post-surgical pain: new frontiers in risk factor identification, prevention and management. Br J Pain. 2017;11(4):169–177. doi: 10.1177/2049463717720636.
    1. Montgomery GH, Bovbjerg DH, Schnur JB, et al. A randomized clinical trial of a brief hypnosis intervention to control side effects in breast surgery patients. J Natl Cancer Inst. 2007;99(17):1304–1312. doi: 10.1093/jnci/djm106.
    1. Obata H. Analgesic mechanisms of antidepressants for neuropathic pain. Int J Mol Sci. 2017;18(11) doi: 10.3390/ijms18112483.
    1. Sandkühler J, Gruber-Schoffnegger D. Hyperalgesia by synaptic long-term potentiation (LTP): an update. Curr Opin Pharmacol. 2012;12(1):18–27. doi: 10.1016/j.coph.2011.10.018.
    1. Fourie WJ. Considering wider myofascial involvement as a possible contributor to upper extremity dysfunction following treatment for primary breast cancer. J Bodyw Mov Ther. 2008;12(4):349–355. doi: 10.1016/j.jbmt.2008.04.043.
    1. Cheville AL, Tchou J. Barriers to rehabilitation following surgery for primary breast cancer. J Surg Oncol. 2007;95(5):409–418. doi: 10.1002/jso.20782.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit